Melanoma March Update
13 March 2020
MELANOMA MARCH - CANCELLATION OF EVENTS
Statement from Melanoma Institute Australia CEO Matthew Browne
Due to the escalating impact of COVID-19, and in the interests of the health and safety of all participants and attendees, we have made the difficult decision to cancel all remaining Melanoma March events nationally. This includes the seven events scheduled for this weekend - Melbourne, Bunbury, Bendigo, Coolangatta, Macarthur, Mackay, and Wagga Wagga.
This decision has not been made lightly, however protecting the health of our dedicated community members and their families who run and attend these events, many of whom are cancer patients, is paramount.
We will be offering full refunds for registrations. (See below).
We are planning to hold a virtual Melanoma March event on Sunday 29th March to enable our community across Australia to still come together as we have done for Melanoma March for the last 9 years. We will provide more detail regarding this very soon.
My sincere apologies and thanks particularly to our volunteer committees who work tirelessly to put on their local Melanoma March events every year.
UPDATE ON REFUNDS
If you would like a refund for your Melanoma March event registration, please email email@example.com. Otherwise, all registration fees will go towards our overall Melanoma March tally. We are of course still gratefully accepting donations on the Melanoma March website to support development of the national matched immunotherapy platform. Your ongoing support and understanding is greatly appreciated.
An international study, led by researchers from Melanoma Institute Australia, QIMR Berghofer Medical Research Institute and The University of Sydney as part of the Australian Melanoma Genome Project, has discovered that a drug traditionally used to treat a
Researchers from Melanoma Institute Australia took centre stage at the American Society of Clinical Oncology Annual Meeting in Chicago. Results presented by MIA’s contingent have the potential to create better patient outcomes and change the way advanced melanoma
Today is International Clinical Trials Day – a day to recognise and thank the amazing people who conduct, organise, and coordinate clinical trials.
“I’m the age Emma was when she passed away. It almost feels
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.
MIA had four winners in the 2017 Premiers Awards. Find out how winning has influenced their work over the past year.
Cancer Council awards Melanoma Institute Australia researchers funding for ground-breaking cancer research projects
Almost $9 million of new funding was awarded to 13 ground-breaking cancer research projects at the 2019 Cancer Council NSW Research Awards.
Georgina V. Long is co-medical director of Melanoma Institute Australia and Chair of Melanoma Medical Oncology and Translational Research. She is the first woman president of the Society for Melanoma Research.
Quintessential Aussie girl and media personality Sophie Monk has been announced as a National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.
Australian researchers have for the first time identified specific cells and receptors in the immune system which predict how a patient will respond to treatment with immunotherapies, potentially paving the way for the development of personalised therapy for all cancer patients.
Melanoma March is thrilled to introduce Ricky as our official Principal Partner for 2019!
World record holder, Olympian and Australian swimming champion Cate Campbell has been announced as National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.
MIA's expertise was essential to a recent Nature publication spearheaded by Perth’s Telethon Kids Institute and The University of Melbourne.
MIA is delighted to be hosting the MD Anderson pathologist on his first ever trip to Australia.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for dabrafenib and trametinib.
Three students from Arden Anglican School in Epping have won Melanoma Institute Australia’s (MIA) inaugural SunSafe Student Ambassador Award.
Mark Whittaker’s ‘Here comes the sun; Defending our summer rays’ (GW 24 Nov) clouds the sun-safe message – which could have disastrous consequences.
Professor Georgina Long is among only 12 researchers from the University of Sydney to be named in the 2018 Highly Cited Researchers List.
‘Wearing sunscreen should be as automatic as wearing a seatbelt. Both are potential life savers.’